Chen Xuanyu, Zou Ming, Lu Chunxing, Zhou Ruyi, Lou Shuyue, Wang Yujia, Ding Hongxiang, Han Zhao, Hu Beilei
Department of Neurology, Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China.
Clinical Laboratory, Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China.
Front Genet. 2023 Mar 30;14:1132654. doi: 10.3389/fgene.2023.1132654. eCollection 2023.
Dysplasminogenemia is a rare heritable disease caused by plasminogen (PLG) gene defects resulting in hypercoagulability. In this report we describe three notable cases of cerebral infarction (CI) complicated with dysplasminogenemia in young patients. Coagulation indices were examined on STAGO STA-R-MAX analyzer. PLG: A was analyzed using a chromogenic substrate-based approach using a chromogenic substrate method. All nineteen exons of PLG gene and their 5'and 3'flanking regions were amplified by Polymerase chain reaction (PCR). Suspected mutation was confirmed by reverse sequencing. PLG activity (PLG:A) in proband 1 and 3 of his tested family members, proband 2 and 2 of his tested family members, and proband 3 and her father were all reduced to roughly 50% of normal levels. Sequencing led to the identification of a heterozygous c.1858G>A missense mutation in exon 15 of the PLG gene in these three patients and affected family members. We conclude that the observed reduction in PLG:A was the result of this .Ala620Thr missense mutation in the PLG gene. The CI incidence in these probands may be attributable to the inhibition of normal fibrinolytic activity as a consequence of this heterozygous mutation.
异常纤溶酶原血症是一种由纤溶酶原(PLG)基因缺陷导致血液高凝状态的罕见遗传性疾病。在本报告中,我们描述了3例年轻患者发生脑梗死(CI)并合并异常纤溶酶原血症的显著病例。使用STAGO STA-R-MAX分析仪检测凝血指标。采用基于发色底物的方法,使用发色底物法分析PLG:A。通过聚合酶链反应(PCR)扩增PLG基因的全部19个外显子及其5'和3'侧翼区域。通过反向测序确认疑似突变。先证者1及其3名受检家庭成员、先证者2及其2名受检家庭成员以及先证者3及其父亲的PLG活性(PLG:A)均降至正常水平的约50%。测序结果显示,这3例患者及其受影响的家庭成员在PLG基因第15外显子中存在杂合性c.1858G>A错义突变。我们得出结论,观察到的PLG:A降低是PLG基因中这种Ala620Thr错义突变的结果。这些先证者发生CI的情况可能归因于这种杂合突变对正常纤维蛋白溶解活性的抑制。